| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
|
Iqbal, Syma
|
|
2011
|
68 |
6 |
p. 1595-1602
|
artikel
|
| 2 |
A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors
|
Leijen, Suzanne
|
|
2011
|
68 |
6 |
p. 1619-1628
|
artikel
|
| 3 |
Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial
|
Fogelman, David
|
|
2011
|
68 |
6 |
p. 1431-1438
|
artikel
|
| 4 |
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation
|
Metro, Giulio
|
|
2011
|
68 |
6 |
p. 1405-1412
|
artikel
|
| 5 |
Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy
|
Egawa-Takata, Tomomi
|
|
2011
|
68 |
6 |
p. 1603-1610
|
artikel
|
| 6 |
Comparison of different semi-mechanistic models for chemotherapy-related neutropenia: application to BI 2536 a Plk-1 inhibitor
|
Soto, Elena
|
|
2011
|
68 |
6 |
p. 1517-1527
|
artikel
|
| 7 |
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway
|
Wang, Shuang-Jia
|
|
2011
|
68 |
6 |
p. 1421-1430
|
artikel
|
| 8 |
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study
|
Leal, Ticiana B.
|
|
2011
|
68 |
6 |
p. 1439-1447
|
artikel
|
| 9 |
Erufosine, an alkylphosphocholine, with differential toxicity to human cancer cells and bone marrow cells
|
Bagley, Rebecca G.
|
|
2011
|
68 |
6 |
p. 1537-1546
|
artikel
|
| 10 |
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity
|
Guilhaumou, Romain
|
|
2011
|
68 |
6 |
p. 1633-1638
|
artikel
|
| 11 |
Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumors
|
LoRusso, Patricia
|
|
2011
|
68 |
6 |
p. 1377-1385
|
artikel
|
| 12 |
Pharmacokinetic evaluation of the vinorelbine–lapatinib combination in the treatment of breast cancer patients
|
Rezai, Keyvan
|
|
2011
|
68 |
6 |
p. 1529-1536
|
artikel
|
| 13 |
Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer
|
Tsimberidou, Apostolia-Maria
|
|
2011
|
68 |
6 |
p. 1507-1516
|
artikel
|
| 14 |
Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
|
Staveren, Maurice C. van
|
|
2011
|
68 |
6 |
p. 1611-1617
|
artikel
|
| 15 |
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma
|
Norris, Robin E.
|
|
2011
|
68 |
6 |
p. 1469-1475
|
artikel
|
| 16 |
Preclinical evaluation of the novel multi-targeted agent R1530
|
Kolinsky, Kenneth
|
|
2011
|
68 |
6 |
p. 1585-1594
|
artikel
|
| 17 |
Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model
|
Berglin, Cecilia Engmér
|
|
2011
|
68 |
6 |
p. 1547-1556
|
artikel
|
| 18 |
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials
|
Binder, Daniel
|
|
2011
|
68 |
6 |
p. 1575-1583
|
artikel
|
| 19 |
Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation
|
Xavier, Cristina P. R.
|
|
2011
|
68 |
6 |
p. 1449-1457
|
artikel
|
| 20 |
Resveratrol induces SIRT1- and energy–stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment
|
Björklund, My
|
|
2011
|
68 |
6 |
p. 1459-1467
|
artikel
|
| 21 |
Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression
|
Takeuchi, Ario
|
|
2011
|
68 |
6 |
p. 1557-1564
|
artikel
|
| 22 |
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
|
Farinati, Fabio
|
|
2011
|
68 |
6 |
p. 1639-1640
|
artikel
|
| 23 |
Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
|
Kim, Jeong Eun
|
|
2011
|
68 |
6 |
p. 1641-1642
|
artikel
|
| 24 |
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies
|
Schöffski, P.
|
|
2011
|
68 |
6 |
p. 1397-1403
|
artikel
|
| 25 |
Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors
|
Saif, Muhammad Wasif
|
|
2011
|
68 |
6 |
p. 1565-1573
|
artikel
|
| 26 |
The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib
|
Horak, Jiri
|
|
2011
|
68 |
6 |
p. 1485-1495
|
artikel
|
| 27 |
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients
|
Ramírez, Jacqueline
|
|
2011
|
68 |
6 |
p. 1629-1632
|
artikel
|
| 28 |
t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo, Sung-Hsin
|
|
2011
|
68 |
6 |
p. 1387-1395
|
artikel
|
| 29 |
Translational research of a novel humanized epidermal growth factor receptor-related protein: a putative inhibitor of pan-ErbB
|
Fu, Xian-Hua
|
|
2011
|
68 |
6 |
p. 1373-1376
|
artikel
|
| 30 |
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study
|
Chang, Peter Mu-Hsin
|
|
2011
|
68 |
6 |
p. 1477-1484
|
artikel
|
| 31 |
Tumor growth modeling from clinical trials reveals synergistic anticancer effect of the capecitabine and docetaxel combination in metastatic breast cancer
|
Frances, N.
|
|
2011
|
68 |
6 |
p. 1413-1419
|
artikel
|
| 32 |
Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer
|
Sen, Fatma
|
|
2011
|
68 |
6 |
p. 1497-1505
|
artikel
|
Tijdschrift beschrijving